The road to the commercial contraceptive market is a “constant battle,” admits Michael O’Rand, Ph.D. For nearly a decade, O’Rand’s company Eppin Pharma Inc. has been traveling the long and expensive path of developing a drug that has the potential to completely transform family planning: a male birth control pill. “It costs hundreds of millions of dollars
Here's our latest roundup of upcoming events and deadlines across the Triangle through the end of December. This holiday-themed edition features festive parties and other end-of-year events.
Triangle Venture Day, hosted at Apella by Alexandria at the Alexandria Center for Advanced Technologies campus, proved to be one of promise of the Triangle’s growing innovation ecosystem, optimism for high-impact science, and enthusiasm for local collaboration.
WIN chose a long-term investment in SonoVascular for several reasons including the product’s large total and serviceable addressable market, excellent unit economics, and all-star leadership and technical teams.
The North Carolina Biotechnology Center will host the conference “Aligning Health Care Innovation in North Carolina: Health Systems, Payers, Innovators, and the Quintuple Aim” on April 27. Here's a preview.